Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by S100A4 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. Additionally we are shipping s100a4 Kits (42) and s100a4 Proteins (41) and many more products for this protein.
Showing 10 out of 303 products:
Human Monoclonal s100a4 Primary Antibody for IF, ELISA - ABIN562767
Nishioku, Furusho, Tomita, Ohishi, Dohgu, Shuto, Yamauchi, Kataoka: Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. in Neuroscience 2011
Show all 5 Pubmed References
Human Polyclonal s100a4 Primary Antibody for IHC (p), IHC - ABIN188680
Jiang, Xu, Mao, Li, Fang, Zhou, Liu, He, Zhao, Yang, Dai: Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. in Journal of the American Society of Nephrology : JASN 2013
Show all 2 Pubmed References
Human Polyclonal s100a4 Primary Antibody for IHC, IHC (p) - ABIN4351669
Laguë, Detmar, Paquet, Boyer, Richards, Adamson, Boerboom: Decidual PTEN expression is required for trophoblast invasion in the mouse. in American journal of physiology. Endocrinology and metabolism 2010
Show all 2 Pubmed References
Human Polyclonal s100a4 Primary Antibody for ELISA, WB - ABIN562766
Chen, Wang, Wu, Su, Hong, Chuang, Chen, Hua, Wu, Cha, Babu, Chen, Lee, Chang, Kuo: CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. in Journal of cell science 2007
Human Polyclonal s100a4 Primary Antibody for IHC, ELISA - ABIN334485
Li, Bresnick: The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. in Cancer research 2006
Show all 2 Pubmed References
miR (show MLXIP Antibodies)-3189-3p mimics enhanced the effects of the S100A4 siRNA on the inhibition of gastric cancer cell proliferation and migration by targeting CFL2 (show CFL2 Antibodies).
Urine S100A4 shows the most promise as an lupus nephritis (LN) activity biomarker.
S100A4 is up-regulated in cervical adenocarcinomas and squamous cell carcinomas.
Network analysis of overlapping genes revealed the effects on tubulins (Tubb2a, Tubb3, Tubb4b), Nfe2l2, S100a4, Cd44, and Nfkb2, all of which are linked to TBI-relevant outcomes, including epileptogenesis and tissue repair
Authors first provide experimental evidence suggesting that FAM107B was downregulated by S100A4 in gastric cancer MGC803 cells. And FAM107B at least partially mediates the biological effect of S100A4 in the cells.
MiR (show MLXIP Antibodies)-187 could interact with S100A4 3'-UTR (show UTS2R Antibodies).
Both the calcium-binding ability and the C-terminal region of S100A4 are important for cancer initiatin cells to sustain their stemness properties and malignancy in head and neck cancers.
Studied the role and expression of MIR296 in the metastasis and epithelial-mesenchymal transition of colorectal cancer. Found MIR296 inhibited migration and invasion of tumor cells, as well as suppressed S100A4 abundance in tumor cells.
S100A4-expression was associated with poor outcome in early-stage breast cancer, but the low percentage of positive tumors and the modest survival differences imply that the clinical utility in selection of patients for adjuvant treatment is limited.
The relative expression of S100A4 mRNA was higher when mod (show MOD(MDG4) Antibodies)-SHEM was used, although significant differences were detected only when the expression levels were compared with those found in LPCs incubated with IOBA-FBS (show FBXO8 Antibodies)
The Smad3 (show SMAD3 Antibodies) and Bmal1 (show ARNTL Antibodies) regulate p21 (show D4S234E Antibodies) and S100A4 expression in myocardial stromal fibroblasts through TNF-alpha (show TNF Antibodies).
High S100A4 expression is associated with Mesenchymal Transition in Glioblastoma.
findings indicate that Idiopathic pulmonary fibrosis mesenchymal progenitor cells are intrinsically fibrogenic and that S100A4 confers mesenchymal progenitor cells with fibrogenicity.
Data provide the first report on the in vivo role of S100a4 in intestinal tumourigenesis and describe a new role for S100a4 in the aetiology of desmoids formation.
S100A4 expression protects cardiac myocytes against myocardial ischemia and is required for stabilization of cardiac function after MI.
These findings provide further evidence on extracellular S100A4 as paracrine mediator of prometastatic endothelial dysfunction involving its interaction with RAGE (show AGER Antibodies).
this study has demonstrated a crucial role for retinoic acid in promoting IL-22 (show IL22 Antibodies) production and tempering dendritic cell function through downregulating S100A4 protein during viral hepatitis
Extracellular S100A4 is important for the regulation of bone formation by activating the NF-kappaB (show NFKB1 Antibodies) signaling pathway in osteoblasts.
Interaction of extracellular S100A4 with RAGE (show AGER Antibodies) prompts prometastatic activation of melanoma cells.
Our results indicated that RNV was ameliorated by Ad-S100A4-RNAi transfer in a mouse model of OIR through mediation of the anti-apoptotic effect of Bcl-2 (show BCL2 Antibodies) by reducing the expression of CREB (show CREB1 Antibodies).
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified.
S100 calcium binding protein A4
, S100 calcium-binding protein A4
, S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, fibroblast-specific protein-1
, leukemia multidrug resistance associated protein
, malignant transformation suppression 1
, placental calcium-binding protein
, protein Mts1
, protein S100-A4
, S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, S100 calcium-binding protein A4 (calcium protein,calvasculin, metastasin, murine placental homolog)
, placental calcium-binding protein homolog
, metastatic cell protein
, protein 18A2
, Protein 9 Ka homologous to calcium-binding protein
, nerve growth factor-induced protein 42A